CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Obradovic, Aleksandar Lj ^a,b   Hwang, Sung Mi ^a,c   Scarpa, Joseph ^a   Hong, Sung Jun ^a,c   Todorovic, Slobodan M ^a,d   Jevtovic Todorovic, Vesna ^a,d  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c Hallym University   (South Korea)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CALCIUM CHANNEL T TYPE; CALCIUM CHANNEL T TYPE CAV3.2; MIBEFRADIL; MORPHINE; UNCLASSIFIED DRUG; CACNA1H PROTEIN, RAT; CALCIUM CHANNEL BLOCKING AGENT; STREPTOZOCIN;

ADULT; ALLODYNIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CURRENT; COLD SENSITIVITY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG TARGETING; FEMALE; HEAT SENSITIVITY; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PATCH CLAMP TECHNIQUE; PROTEIN FUNCTION; RAT; SENSORY NERVE CELL; SPINAL GANGLION; STREPTOZOTOCIN-INDUCED DIABETIC NEUROPATHY; ANIMAL; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DRUG EFFECTS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FEMALE; HYPERALGESIA; MIBEFRADIL; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; STREPTOZOCIN;

EID: 84899416991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091467     Document Type: Article

References (36)

1. Messinger RB, Naik AK, Jagodic MM, Nelson MT, Lee WY, et al. (2009) Invivo silencing of the Cav3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain 145: 184-195.
2. Jagodic MM, Pathirathna S, Nelson MT, Mancuso S, Joksovic PM, et al. (2007) Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci 27: 3305-3316. (Pubitemid 46474118)
3. Khomula EV, Viatchenko-Karpinski VY, Borisyuk AL, Duzhyy DE, Belan PV, et al. (2013) Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy. Biochim Biophys Acta 1832: 636-649.
4. Latham JR, Pathirathna S, Jagodic MM, Choe WJ, Levin ME, et al. (2009) Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice. Diabetes 58: 2656-2665.
5. Choe WJ, Messinger RB, Leach E, Eckle V-S, Obradovic A, et al. (2011) TTAP2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent. Mol Pharm 80: 900-910.
6. Kraus RL, Li Y, Gregan Y, Gotter AL, Uebele VN, et al. (2010) In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice. J Pharmacol Exp Ther 335: 409-17.
7. Uebele VN, Gotter AL, Nuss CE, Kraus RL, Doran SM, et al. (2009) Antagonism of T-type calcium channels inhibits high-fat diet-induced weight gain in mice. J Clin Invest 119: 1659-67.
8. Naik AK, Pathirathna S, Jevtovic-Todorovic V (2008) GABAA receptor modulation in dorsal root ganglia in vivo affects chronic pain after nerve injury. Neuroscience 154: 1539-1553.
9. Bourinet E, Alloui A, Monteil A, Barrere C, Couette B, et al. (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24: 315-324. (Pubitemid 40216136)
10. Hargreaves K, Dubner R, Brown F, Flores C, Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
11. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63. (Pubitemid 24238751)
12. Choi Y, Yoon YW, Na HS, Kim SH, Chung JM (1994) Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain 59: 369-76.
13. Flatters SJ, Bennett GJ (2004) Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain 109: 150-61. (Pubitemid 38479781)
14. Hulse RP, Donaldson LF, Wynick D (2012) Differential roles of galanin on mechanical and cooling responses at the primary afferent nociceptor. Mol Pain 6: 8-41
15. 2+ current in adult rat sensory neurons: Effects of anticonvulsant and anesthetic agents. J Neurophysiol 79: 240-252.
16. Todorovic SM, Meyenburg A, Jevtovic-Todorovic V (2002) Mechanical and thermal antinociception in rats following systemic administration of mibefradil, a T-type calcium channel blocker. Brain Research 951: 336-340. (Pubitemid 35248032)
17. Karam H, Clozel JP, Bruneval P, Gonzalez MF, Ménard J (1999) Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Hypertension 34: 673-8. (Pubitemid 29496452)
18. Paquette F, Jasmin G, Dumont L (1999) Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters. Cardiovasc Drugs Ther 13: 525-30. (Pubitemid 30032260)
19. Sandmann S, Claas R, Cleutjens JP, Daemen MJ, Unger T (2001) Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats. J Cardiovasc Pharmacol 37: 64-77. (Pubitemid 32012933)
20. Barrière DA, Rieusset J, Chanteranne D, Busserolles J, Chauvin MA, et al. (2012) Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization. Pain 153: 553-61.
21. Szallasi A (2013) Targeting TRP channels for pain relief. Eur J Pharmacol Epub 716: 61-76.
22. Todorovic SM, Jevtovic-Todorovic V (2011) T-type voltage-gated calcium channel as targets for the developments of novel pain therapies. Brit J Pharmacol 163: 484-495.
23. Clozel J-P, Ertel EA, Ertel I (1997) Discovery and main pharmacological properties of mibefradil (R0 40-5967), the first selective T-type calcium channel blocker. J Hypertension Suppl 15: S17-S25. (Pubitemid 28034980)
24. 2+ channels and pharmacological blockade: potential pathophysiological relevance. Cardiovascular Drugs and Therapy 11:723-739.
25. McDonough SI, Bean BP (1998) Mibefradil inhibition of T-type calcium channels in cerebellar purkinje neurons. Mol Pharm 54:1080-1087. (Pubitemid 29002052)
26. Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, et al. (2003) Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 105:159-168. (Pubitemid 37162485)
27. Jimenez C, Bourinet E, Leuranguer V, Richard S, Snutch TP, et al. (2000) Determinants of voltage-dependent inactivation affect Mibefradil block of calcium channels. Neuropharmacology 39: 1-10.
28. McNulty MM, Hanck DA (2004) State-dependent mibefradil block of Na+ channels. Mol Pharmacol 66:1652-1661.
29. Viana F, Van den Bosch L, Missiaen L, Vandenberghe W, Droogmans G, et al. (1997) Mibefradil (Ro 40-5967) blocks multiple types of voltage-gated calcium channels in cultured rat spinal motoneurones. Cell Calcium 22: 299-311. (Pubitemid 27490309)
30. Wu ZZ, Chen SR, Pan HL (2004) Differential sensitivity of N- and P/Q-type Ca2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther 311: 939-47.
31. Barbara G, Alloui A, Nargeot J, Lory P, Eschalier A, et al. (2009) T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci 29: 13106-14.
32. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: Mechanisms to management. Pharmacology & Therapeutics 120: 1-34.
33. Reid G, Flonta ML (2001) Physiology. Cold current in thermoreceptive neurons. Nature 413: 480. (Pubitemid 32938740)
34. Nelson MT, Joksovic PM, Perez-Reyes E, Todorovic SM (2005) The endogenous redox agent L-cysteine induces T-type Ca2+ channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors. J Neurosci 25: 8766-8775. (Pubitemid 41362055)
35. Nelson MT, Woo J, Kang H-W, Barrett PQ, Vitko J, et al. (2007) Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of Ttype calcium channels. J Neurosci 27: 8250-8260. (Pubitemid 47219607)
36. Viana F, de la Pena E, Belmonte C (2002) Specificity of cold thermotransduction is determined by differential ionic channel expression. Nat Neurosci 5: 254-260. (Pubitemid 34171139)